---
title: "Inari Medical completes LimFlow acquisition for CLTI treatment"
date: "2023-11-23T16:20:42.000Z"
publishedDate: "23 novembre 2023"
summary: "Inari Medical has announced that it has completed its acquisition of chronic limb-threatening ischaemia (CLTI) treatment maker LimFlow. The Irvine, California–based company earlier this month announced plans to acquire LimFlow for up to US$415 million."
importance: ""
sourceUrl: "https://interventionalnews.com/inari-medical-completes-limflow-acquisition-for-clti-treatment/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-11-23-inari-medical-completes-limflow-acquisition-for-clti-treatment"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Vein-becoming-artery-with-LimFlow-crossing-stent.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/inari-medical-completes-limflow-acquisition-for-clti-treatment/"
---

![Inari Medical completes LimFlow acquisition for CLTI treatment](https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Vein-becoming-artery-with-LimFlow-crossing-stent.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/inari-medical-completes-limflow-acquisition-for-clti-treatment/*

## L’essentiel

Inari Medical has announced that it has completed its acquisition of chronic limb-threatening ischaemia (CLTI) treatment maker LimFlow. The Irvine, California–based company earlier this month announced plans to acquire LimFlow for up to US$415 million.

## Lien source

https://interventionalnews.com/inari-medical-completes-limflow-acquisition-for-clti-treatment/
